从miRNA 探索中西药物治疗肾脏病
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692

基金项目:

浙江省中医药科技计划青年人才基金项目(2021ZQ061)


Exploring the Treatment of Kidney Disease with Traditional Chinese and Western Medicine from miRNA
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    近些年肾脏病发病率逐年增加,目前还没有特异性的药物可以逆转肾衰竭进展过程。如何有效地减缓疾病的进展,保护肾功能成为亟待解决的问题。从基因分子水平对肾脏病的中西医药物治疗进行综述。微小RNA(miRNA) 一定程度上阐明了药物的作用机制,不仅为降低药物肾脏副作用提供了思路,而且证明了药物的护肾作用,为药物的临床应用提供了理论基础。

    Abstract:

    Abstract:The incidence rate of kidney disease has increased year by year, and there is no specific drug that can reverse the progression of renal failure. How to effectively slow down the progress of disease and protect renal function has become an urgent problem to be solved. This paper reviews the treatment of kidney disease with traditional Chinese and western medicine at the gene and molecular level. microRNA(miRNA) clarified the action mechanism of drugs to a certain extent, which not only provided ideas for reducing the renal side effects of drugs, but also proved the renal protection effect of drugs, and provided a theoretical basis for the clinical application of drugs.

    参考文献
    相似文献
    引证文献
引用本文

张永颜,张绍杰,李亚妤.从miRNA 探索中西药物治疗肾脏病[J].新中医,2022,54(3):13-16

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-02-14
  • 出版日期:
文章二维码